This study describes the identification of an antibiotic class acting via LpxH, involved in lipopolysaccharide synthesis having potent in vivo efficacy against bloodstream infections caused by the critical Gram-negative pathogens E. coli and Klebsiella pneumoniae. Further development of this class of antibiotics could make an important contribution to the ongoing struggle against antibiotic resistance.
https://www.pnas.org/doi/10.1073/pnas.2317274121 (open access)
Good, now use it SPARINGLY unlike zpack
Agreed! Haha just kidding, prescription machine goes brrrrr
Also, gotta keep the supply of animal products up somehow! (/s, end animal agriculture)
Yes, this is SPARTA! Pour it on everything quickly or we might all die!!1!
Average biochemistry win.
More antibiotics is not the solution. We need to be moving away from antibiotics, and drastically decreasing their use/overuse.
Goodluck with that.
